Replies to post #100881 on Biotech Values

[genisi]

I would wait until I see data from phase III trial against warfarin for stroke prevention in AF setting (ROCKET-AF)
http://clinicaltrials.gov/ct2/show/NCT00403767?term=xarelto&phase=2&rank=3 mainly because of the tendency for increased bleeding.